Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II Trametinib in Patients with Unresectable or Metastatic Epithelioid Hemangioendothelioma

Protocol: OSU-17131

Full Title

A Non-Randomized, Open-Label, Phase 2 Study of Trametinib in Patients with Unresectable or Metastatic Epithelioid Hemangioendothelioma